Indira IVF has announced its entry into diagnostics with ‘Indira PathLabs’. It will offer pathology tests catering to the needs of women and child. The organisation has inaugurated its laboratories in Lucknow, New Delhi, Patna and Mumbai, and aims to launch a total of 30+ pathology laboratories in strategic geographies by FY24 and two super speciality labs in Mumbai and Delhi.
Indira PathLabs will leverage Indira IVF’s already established network of 114 centres in the country. In the Phase 1 of expansion in FY23, it will gradually expand services to all major geographies where it has a presence including Lucknow, Patna, New Delhi, Mumbai, Pune, Udaipur, Jaipur, Varanasi, Kolkata, Ranchi, Bhubaneswar, and Bengaluru to name a few.
Commenting on the addition of Indira PathLabs, Dr Nitiz Murdia, Managing Director & Co-Founder, Indira IVF said, “With this integration, we will be able to address the full spectrum of diagnostics needs of women from the time of planning for a pregnancy to conception and delivery. Regular testing for different vitals becomes essential on this journey and we hope to help aspiring mothers through recommendations of our gynaecologist partners. Furthermore, genetic testing is an essential tool to ascertain the future child’s health and check for the presence of any genetic anomalies. In this regard, in addition to our pathology services, we also seek to introduce two genetic testing laboratories in the country that can perform highly specialised tests required for the prediction of such genetic anomalies in the child conceived.”
Addressing the requirement of women and child diagnostic needs, Dr Kshitiz Murdia, CEO & Co-Founder, Indira IVF said, “Given the requirement for our own IVF treatments, it is a strategic decision to launch specialty pathology laboratories which will not only meet the requirements of our patients to complete the whole cycle with us but will also answer the need of trusted diagnostics care for all.”
Discussion about this post